AANEM News Express

AANEM News Express

Science News: A Novel Autoantibody Against Plexin D1 in Patients with Neuropathic Pain

1/31/2019
 
Submitted by: Clark Pinyan, MD, MPH
Edited by: Bryan DeSouza, MD


Fulii T, Yamasaki R, Iinuma K, et al. A novel autoantibody against plexin D1 in patients with neuropathic pain. Annals of Neurology. 2018;84(2):208-224. 
 
The authors actively sought novel autoantibodies in patients with neuropathic pain. Among 110 patients with neuropathic pain tested by tissue based IFA, 11 patients had a characteristic pattern of binding to mouse unmyelinated C‐fiber type dorsal root ganglion (DRG) neurons. Mass spectrometry analysis of the immunoprecipitant yielded a partial sequence identical to plexin D1 amino acids. Most of these patients had other identified immune conditions including Sjogren’s syndrome, asthma, and allergic rhinitis. The majority were young (26.3 ± 13.3), female (81.8%) and had relapsing or fluctuating clinical courses (100%). Seven patients underwent immunotherapy for related conditions, and all 7 reported improvement in neuropathic pain. 

Comment: This paper is an important first step in identifying biomarkers for neuropathic pain in a cohort of Japanese patients. 10% of the neuropathic pain patients were found to have anti-unmyelinated C‐fiber type DRG neuronal antibodies directed against the plexin D1 antigen. Although this is an important finding, the majority – 90% of the neuropathic patients screened – did not have these autoantibodies. A majority were candidates for immunotherapy based on other systemic diagnoses (most commonly Sjogren’s syndrome), and all noted improvement in pain with treatment. This article highlights the growing importance of autoantibodies in neuropathic processes including pain.


View Related News Stories:

  EducationScience News


Recent AANEM News

Science News: Six-Month Assessment of a Hand Prosthesis with Intraneural Tactile Feedback

Dr. Peter Grant’s Expert Testimony Helps Convict Texas Doctor and Hospital Owner in $20 Million Healthcare Fraud Scheme

Science News: High Prevalence of Neutralizing Antibodies After Long-term Botulinum Neurotoxin Therapy

Submit Your Abstract for the Myasthenia Gravis Foundation of America’s 2019 Scientific Session!

Register Now for the Wake Forest/AANEM Neuromuscular Ultrasound Workshop - June 27-28, 2019





Advertisement

TPP

Advertisement

ABEM

Advertisement

Find Your Dream Job